entrinsic bioscience Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 29
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 9

entrinsic bioscience General Information

Description

Developer of dietary supplements designed to address critical digestive health problems in humans and animals around the world. The company's supplements provide amino acids and electrolytes that help to manage gastrointestinal (GI) dysfunction that occurs from the treatment of cancer, by rebuilding and protecting the gastrointestinal tract delivering total body hydration, enabling patients to get relief from the side effects caused by chemotherapy or radiation therapy.

Contact Information

Formerly Known As
Entrinsic Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 100 River Ridge Drive
  • Suite 206
  • Norwood, MA 02062
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

entrinsic bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 000.00 Completed Generating Revenue
6. Later Stage VC 28-Aug-2018 000.00 000.00 Completed Generating Revenue
5. Accelerator/Incubator 000.00 Completed Startup
4. Grant 17-May-2016 000.00 Completed Startup
3. Early Stage VC (Series B) 04-Mar-2016 00.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 31-Jan-2015 $5.12M $5.12M 000.00 Completed Startup
1. Grant 01-Jan-2015 $500K Completed Startup
To view entrinsic bioscience’s complete valuation and funding history, request access »

entrinsic bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view entrinsic bioscience’s complete cap table history, request access »

entrinsic bioscience Executive Team (15)

Name Title Board Seat Contact Info
Stephen Gatto Chairman & Chief Executive Officer
Mario Wanderley Chief Financial Officer
Daniel Dennison Ph.D Chief Technology Officer & Board Member
Joseph Del Regno Chief Marketing Officer
Sadasivan Vidyasagar Ph.D Co-Founder & Chairman of Scientific Advisory Board
You’re viewing 5 of 15 executive team members. Get the full list »

entrinsic bioscience Board Members (12)

Name Representing Role Since
Brian Fox entrinsic bioscience Board Member 000 0000
Byron Kalogerou JD McDermott Will & Emery Board Member 000 0000
Charlie Raffin entrinsic bioscience Board Observer 000 0000
Charlotte Hubbert Ph.D Self Board Member 000 0000
Daniel Dennison Ph.D entrinsic bioscience Chief Technology Officer & Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

entrinsic bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

entrinsic bioscience Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Space Biomedical Research Institute Government 000 0000 000000 0
Johnson & Johnson Corporation Minority 000 0000 000000 0
Junonia Capital, LLC Venture Capital Minority 000 0000 000000 0
SmartCap Venture Capital Minority 000 0000 000000 0
Enterade Investment Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »